Episode Details
Back to Episodes
FDA Approves New Maintenance Drug for HER2 Positive Breast Cancer
Published 15 hours ago
Description
A new three-drug maintenance regimen extends progression-free survival for advanced HER2-positive breast cancer patients by more than eight months.